There are generic Tambocor (flecainide) tablets available in three different strengths, including 50 mg, 100 mg, and 150 mg. The U.S. Food and Drug Administration has tested these generic drugs and determined that they are equivalent to brand-name Tambocor. However, the generics may contain different inactive ingredients than brand-name Tambocor tablets.
Tambocor™ (flecainide acetate) is a prescription medication approved to prevent certain types of abnormal heartbeats, or arrhythmias. It is used when the arrhythmia is considered life-threatening or associated with disabling symptoms.
Tambocor is made by 3M Drug Delivery Systems for Medicis. It is no longer protected by patents and is available in generic form.
Generic Tambocor tablets are available in the following strengths:
- Flecainide 50 mg
- Flecainide 100 mg
- Flecainide 150 mg.
Generic Tambocor is made by several companies, including:
- Amneal Pharmaceuticals
- Teva Pharmaceuticals
- Ranbaxy Pharmaceuticals
- Roxane Laboratories, Inc.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic versions of Tambocor currently available have an "AB" rating, meaning they should be equivalent to Tambocor.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.